Lynch & Associates IN Trims Stock Position in Colgate-Palmolive (NYSE:CL)

Lynch & Associates IN decreased its position in shares of Colgate-Palmolive (NYSE:CL) by 2.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 25,926 shares of the company’s stock after selling 781 shares during the quarter. Lynch & Associates IN’s holdings in Colgate-Palmolive were worth $2,357,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bruce G. Allen Investments LLC boosted its stake in Colgate-Palmolive by 5.6% during the 4th quarter. Bruce G. Allen Investments LLC now owns 5,596 shares of the company’s stock worth $509,000 after purchasing an additional 295 shares during the period. Harbor Capital Advisors Inc. raised its holdings in shares of Colgate-Palmolive by 5.3% in the fourth quarter. Harbor Capital Advisors Inc. now owns 13,874 shares of the company’s stock valued at $1,261,000 after buying an additional 702 shares during the last quarter. Hilltop National Bank boosted its stake in shares of Colgate-Palmolive by 22.3% during the fourth quarter. Hilltop National Bank now owns 2,409 shares of the company’s stock worth $219,000 after buying an additional 440 shares during the period. Northcape Capital Pty Ltd grew its holdings in shares of Colgate-Palmolive by 4.9% during the fourth quarter. Northcape Capital Pty Ltd now owns 6,012 shares of the company’s stock worth $547,000 after buying an additional 282 shares during the last quarter. Finally, Range Financial Group LLC increased its position in Colgate-Palmolive by 117.8% in the 4th quarter. Range Financial Group LLC now owns 10,436 shares of the company’s stock valued at $949,000 after acquiring an additional 5,644 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Insiders Place Their Bets

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 0.34% of the stock is owned by corporate insiders.

Colgate-Palmolive Trading Down 1.2 %

NYSE:CL traded down $1.08 on Friday, reaching $86.38. The stock had a trading volume of 5,934,379 shares, compared to its average volume of 4,611,294. Colgate-Palmolive has a 12-month low of $79.69 and a 12-month high of $109.30. The firm’s fifty day moving average is $92.76 and its two-hundred day moving average is $98.15. The company has a market cap of $70.57 billion, a price-to-earnings ratio of 24.75, a P/E/G ratio of 3.31 and a beta of 0.44. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Investors of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date of this dividend is Tuesday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.32%. Colgate-Palmolive’s payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

A number of research analysts have recently issued reports on the company. Piper Sandler dropped their target price on Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating on the stock in a report on Monday. Wells Fargo & Company dropped their price objective on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday. JPMorgan Chase & Co. lifted their target price on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. TD Cowen reduced their price objective on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday. Finally, StockNews.com cut Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, Colgate-Palmolive currently has an average rating of “Hold” and a consensus target price of $103.63.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.